Black patients with AML are younger at diagnosis, experience poorer survival outcomes than white patients, data show

Compared with white patients, Black patients with acute myeloid leukemia (AML) were on average more than five years younger at diagnosis, more than 30% more likely to die of their disease, and more than 20% more likely to die of any cause,…

Continue Reading

News Source: medicalxpress.com